| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 122.553 | 107.144 | 16.960 |
| Total Income - EUR | - | - | - | - | - | 0 | 0 | 122.553 | 107.148 | 16.979 |
| Total Expenses - EUR | - | - | - | - | - | 6.411 | 1.089 | 83.277 | 1.266 | 1.148 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -6.411 | -1.089 | 39.276 | 105.883 | 15.831 |
| Net Profit/Loss - EUR | - | - | - | - | - | -6.411 | -1.089 | 36.078 | 89.698 | 13.425 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Rudik Professional Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 1.884 | 1.537 | 113.269 | 138.458 | 62.564 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 1.218 | 1.373 | 113.169 | 106.545 | 38.971 |
| Cash | - | - | - | - | - | 667 | 164 | 100 | 31.913 | 23.593 |
| Shareholders Funds | - | - | - | - | - | -6.370 | -7.317 | 28.738 | 89.747 | 13.473 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 8.331 | 8.854 | 84.531 | 79.036 | 79.246 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Rudik Professional Pharma S.r.l.